Switzerland· 59329001
Victoza 6 mg/ml, Fertigpen (Triple-Dose)
A liraglutide product containing liraglutidum, registered in Switzerland by Novo Nordisk Pharma AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Liraglutide is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BJ02 (liraglutide), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 10 of them publish a price we can compare per daily dose
Liraglutide · ATC A10BJ02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- liraglutidum
- Manufacturer
- Novo Nordisk Pharma AG
- Country
- Switzerland (CH)
- ATC code
- A10BJ02
- ATC class
- Liraglutide
- Defined daily dose
- 1.5 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76805932900142 Fertigpen 3 mlCHF 107.1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
309 interactions on record for liraglutide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Liraglutide · interactions on record
309 records
- 3 severe
- 260 moderate
- 46 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Liraglutide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABLYMICOSTADA Arzneimittel AG, Bad Vilbel
- SpainBYESILOR 6 MG/ML SOLUCION INYECTABLE EN PLUMA PRECARGADA EFGSun Pharmaceutical Industries (Europe) B.V.
- SwedenAblymico 6 mg/ml Injektionsvätska, lösning i förfylld injektionspennaSTADA Arzneimittel AG
- PolandAblymicoSTADA Arzneimittel AG
- NorwayLiraglutid zentivaZentiva
- BelgiumAblymico 6 mg/mlStada Arzneimittel
- IcelandSaxendaNovo Nordisk A/S*
- United StatesliraglutideOrbicular Pharmaceutical Technologies Private Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ejulir, Lirabelin
- Belgium · Byesilor, Zinnentis
- Bulgaria · Зеглуксен
- Czechia · Ejulir, Plyzari
- Germany · Byesilor, Diavic
- Denmark · Ejulir, Liraglutid "biogaran"
- Estonia · Liraglutide Zentiva, Siluxir
- Spain · Byesilor, Diavic
- Finland · Diavic, Metlyra
- France · Liendax, Liraglutide Biogaran
- United Kingdom (Northern Ireland) · Diavic, Ligobesy
- Croatia · Zegluxen
- Hungary · Liendax
- Ireland · Ejulir
- Iceland · Ablymico, Liraglutide Stada
- Italy · Byesilor, Diavic
- Liechtenstein · Ablymico, Liraglutide Stada
- Lithuania · Liraglutide Zentiva
- Luxembourg · Zinnentis
- Latvia · Liraglutide Zentiva, Siluxir
- Netherlands · Byesilor, Diavic
- Norway · Ablymico, Liraglutid Zentiva
- Poland · Byesilor, Diavic
- Portugal · Liraglutido Farmoz, Liraglutido Pentafarma
- Romania · Byesilor, Diavic
- Sweden · Diavic, Ejulir
- Slovakia · Sudaclin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/45eecc77-1855-47dd-9b15-512e36248b79 GET /v1/drugs/45eecc77-1855-47dd-9b15-512e36248b79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "liraglutidum 6 mg",
"valid_from": "2010-02-01",
"limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, in ausschliesslicher Kombinationstherapie mit Metformin, einem Sulfonylharnstoff oder einer Kombination aus Metformin und einem Sulfonylharnstoff oder Metformin und einem Thiazolidindion, wenn durch diese oralen Antidiabetika keine ausreichende Blutzuckerkontrolle erreicht wird.<br>\\nIn Kombination mit Basalinsulin ausschliesslich bei Patienten mit ungenügender Blutzuckerkontrolle unter vorgängiger Therapie mit Metformin und VICTOZA.<br>\\nMindestens BMI 28. Zusätzliche Medikamente zur Gewichtsreduktion werden nicht vom Krankenversicherer vergütet.<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2010-02-01\"}]",
"galenic_form": "Inj Lös 6 mg/ml",
"therapeutic_area": null,
"sl_inclusion_date": "2010-02-01",
"self_retention_pct": 10
}See everything about liraglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.